Category: meningococcal disease

Looking Back With Pride….Looking Ahead With Confidence

Over 5 million people in Burkina Faso received the MenAfriVacTM vaccine the first week of December 2010. CDC worked with global partners to help bring the vaccine through clinical development to public health availability. MenAfriVacTM was the first vaccine developed specifically to protect from the meningitis disease strain most destructive to people living in the African meningitis belt.

A historical overview on eliminating Meningitis in Africa In the 1990’s epidemics of meningitis sweeping across the vast span of the African continent known as the “meningitis belt” were claiming hundreds of thousands of lives and there was not much the global public health community was able to do. We all knew that a vaccine Read More >

Posted on by Dr. Nancy Messonnier (CAPT, USPHS) Director for the CDC National Center for Immunization and Respiratory DiseasesTags , , ,